Title |
What can we learn from consumer reports on psychiatric adverse drug reactions with antidepressant medication? Experiences from reports to a consumer association
|
---|---|
Published in |
BMC Clinical Pharmacology, October 2011
|
DOI | 10.1186/1472-6904-11-16 |
Pubmed ID | |
Authors |
Andreas Vilhelmsson, Tommy Svensson, Anna Meeuwisse, Anders Carlsten |
Abstract |
According to the World Health Organization (WHO) the cost of adverse drug reactions (ADRs) in the general population is high and under-reporting by health professionals is a well-recognized problem. Another way to increase ADR reporting is to let the consumers themselves report directly to the authorities. In Sweden it is mandatory for prescribers to report serious ADRs to the Medical Products Agency (MPA), but there are no such regulations for consumers. The non-profit and independent organization Consumer Association for Medicines and Health, KILEN has launched the possibility for consumers to report their perceptions and experiences from their use of medicines in order to strengthen consumer rights within the health care sector. This study aimed to analyze these consumer reports. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Brazil | 2 | 3% |
Norway | 1 | 1% |
Switzerland | 1 | 1% |
Canada | 1 | 1% |
United States | 1 | 1% |
Unknown | 69 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 16 | 21% |
Researcher | 13 | 17% |
Student > Ph. D. Student | 10 | 13% |
Student > Bachelor | 5 | 7% |
Student > Postgraduate | 4 | 5% |
Other | 13 | 17% |
Unknown | 14 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 27% |
Psychology | 10 | 13% |
Nursing and Health Professions | 4 | 5% |
Computer Science | 4 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 5% |
Other | 14 | 19% |
Unknown | 19 | 25% |